Shanghai Clinical Research Center, Shanghai, China.
J Evid Based Med. 2013 May;6(2):104-8. doi: 10.1111/jebm.12036.
As human civilization develops, biomedicine stays robust. Faced with the challenge of Europe Union's Traditional Herbal Medicinal Products Directive, if traditional Chinese medicine (TCM) wants to be still used as one kind of medicine to treat patients, China should be in line with scientific law, that is, each claim that TCM treats any disease or indication should be supported by the data of evidence-based randomized clinical trials. As a priority, there is an urgent need to conduct more scientific experiments and clinical trials to verify the concepts and mechanisms of TCM. Also, China is encouraged to get rid of non-scientific concepts and theories of TCM.
随着人类文明的发展，生物医药领域蓬勃发展。面对欧盟《传统植物药指令》的挑战，如果中药（TCM）仍希望作为一种药物来治疗患者，中国应该遵循科学规律，即 TCM 治疗任何疾病或适应症的每一个说法都应该得到基于证据的随机临床试验数据的支持。作为当务之急，迫切需要开展更多的科学实验和临床试验，以验证 TCM 的概念和机制。此外，中国应鼓励摆脱 TCM 的非科学概念和理论。
Zotero 插件